FIM
AVNS

Freedom Investment Management’s Avanos Medical AVNS Stock Holding History

Freedom Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,151
Closed -$581K – 907
2018
Q2 		$581K Sell
10,151
-1,657
-14% -$87.6K 0.04% 490
2018
Q1 		$544K Buy
+11,808
New +$561K 0.03% 588

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Freedom Investment Management's AVNS Position: Q3 2018 in Review

Freedom Investment Management sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 10,151 shares — an estimated $581K sold.

Freedom Investment Management first reported a position in AVNS in Q1 2018 and held it in 2 quarters. The position peaked at $581K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Freedom Investment Management reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Freedom Investment Management sold 10,151 Avanos Medical shares in Q3 2018, an estimated $581K.
  • Freedom Investment Management first reported a position in Avanos Medical in Q1 2018 and held it in 2 quarters.
  • Freedom Investment Management's Avanos Medical position peaked at $581K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Freedom Investment Management's 13F filing for Q3 2018, filed 17 Oct 2018.